Results 11 to 20 of about 2,315,052 (200)

Potential clinical application of anti-Müllerian hormone testing in radioiodine treatment of thyroid carcinoma

BMC Research Notes
Differentiated thyroid cancer is the most common endocrinological malignancy. Radioiodine treatment has a clear benefit in locally aggressive and metastatic cancers. There are discussions about long-term and acute adverse events.
Barbora Havlínová, Ilona Součková, Kateřina Kopřivová, Jiří Doležal   +3 more
doaj   +2 more sources

Serum Anti-Müllerian Hormone Levels in Patients with Epithelial Ovarian Cancer [PDF]

International Journal of Endocrinology, 2013
Objectives. The aim of our study was to examine serum anti-Müllerian hormone (AMH) concentration in ovarian cancer patients in relation to clinicopathological features, such as a pathological subtype of the tumor, (FIGO) stage, grading, and overall 5 ...
Pawel Walentowicz, Pawel Sadlecki, Magdalena Krintus, Grazyna Sypniewska, Aneta Mankowska-Cyl, Marek Grabiec, Malgorzata Walentowicz-Sadlecka   +6 more
doaj   +2 more sources

A novel mutation in the anti-müllerian hormone gene as cause of persistent müllerian duct syndrome.

, 2001
UNLABELLED Persistent müllerian duct syndrome is a relatively rare inherited defect of sexual differentiation characterised by failure of regression of the müllerian ducts in males. In affected individuals, uterus and tubes are present because of defects
Belville C, Biason-Lauber A, Picard Y, Schoenle EJ, Lang-Muritano M, Gitzelmann C   +5 more
core   +6 more sources

External validation of anti-Müllerian hormone based prediction of live birth in assisted conception [PDF]

, 2013
<p>Background - Chronological age and oocyte yield are independent determinants of live birth in assisted conception. Anti-Müllerian hormone (AMH) is strongly associated with oocyte yield after controlled ovarian stimulation.
Grisendi, V., Lloyd, S.M., McConnachie, A., Fleming, R., Khader, A., La Marca, A., Nelson, S.M.   +6 more
core   +2 more sources

Anti-Müllerian Hormone and Metabolic-Hormonal Profiles in Women With and Without Polycystic Ovary Syndrome: A Population-Based Study. [PDF]

Endocrinol Diabetes Metab
In this population‐based study of 883 women, AMH declined less with age in women with PCOS than in healthy women. Higher AMH may protect older healthy women from T2DM but indicates elevated metabolic risk in younger women with PCOS, supporting its role as a life‐course biomarker for metabolic risk stratification.
Ramezani Tehrani F, Mousavi M, Saei Ghare Naz M, Farahmand M, Jorjani M, Mahboobifard F.   +5 more
europepmc   +2 more sources

Trends in Anti-Müllerian Hormone (AMH) Testing for Fertility Assessment in Australian General Practice, 2011-2021: A Retrospective Open Cohort Study. [PDF]

Aust N Z J Obstet Gynaecol
ABSTRACT Background Anti‐Müllerian hormone (AMH) tests are often promoted as a measure of fertility; however, AMH adds limited predictive value beyond age alone for estimating the likelihood of live birth in couples trying to conceive. Aims This study aimed to examine longitudinal trends in the rate of AMH testing for fertility in the Australian ...
Kassie GM, Copp T, Lensen S, Mazza D, Boyle JA, Grzeskowiak LE.   +5 more
europepmc   +2 more sources

Can Anti-Müllerian hormone predict the diagnosis of polycystic ovary syndrome? : A systematic review and meta-analysis of extracted data [PDF]

, 2013
Context: Existing biochemical tests for polycystic ovary syndrome (PCOS) have poor sensitivity and specificity. Many women with PCOS have high anti-Müllerian hormone (AMH) concentrations; thus, this may be a useful addition to the diagnostic criteria ...
Iliodromiti, S., Kelsey, Tom, Iliodromiti, Stamatina, Anderson, R.A., Nelson, Scott, Kelsey, T.W., Anderson, Richard, Nelson, S.M.   +7 more
core   +1 more source

The Effect of Resistance Training in Water and Land with Vitamin D Supplementation on Anti-Mullerian Hormone in Women with Polycystic Ovary Syndrome [PDF]

Women’s Health Bulletin, 2019
Objectives: This study aimed to investigate the effect of resistance training in water and land with vitamin D on anti-Mullerian hormone in women with polycystic ovary syndrome (PCOS).
Seyed Ali Hosseini, Nasibeh Kazemi, Saeedeh Shadmehri, Shariat Jalili, Mozhgan Ahmadi   +4 more
doaj   +1 more source

The physiology and clinical utility of anti-Müllerian hormone in women [PDF]

, 2014
This paper is a summary of the presentations at the ESHRE campus workshop on AMH in Lille, France, on 10–11 May 2012, with literature update until September 2013.
Kelsey, Tom W, Broekmans, F., Kelsey, Tom W., Visser, J. A., La Marca, A., Griesinger, Georg, Visser, J.A., Nelson, S.M., Lambalk, Cornelius, Dewailly, Didier, Mason, Helen, Nelson, SM, Visser, Jenny A.; id_orcid, Wallace, W Hamish, Griesinger, G, Andersen, CY, Balen, Adam, Visser, Jenny A, Kelsey, T.W., Wallace, W. Hamish, Wallace, W. H., Visser, Jenny; id_orcid, Hamish Wallace, W., Wallace, WH, Andersen, Claus Yding, Nelson, Scott M, Anderson, Richard A, LA MARCA , Antonio, Mason, H, Anderson, R.A., Lambalk, C., La Marca, A, Visser, Jenny A., Broekmans, F, Fanchin, R, Anderson, R. A., Anderson, Richard A., Balen, A., Griesinger, G., Andersen, C.Y., Nelson, Scott M., Dilaver, Nafi, Wallace, W.H., Fanchin, Renato, Mason, H., Dilaver, N, Anderson, RA, Balen, A, La Marca, Antonio, Dewailly, D, Kelsey, TW, Broekmans, Frank, Andersen, C. Y., Lambalk, C.B., Kelsey, T. W., Dewailly, D., Fanchin, R., Dilaver, N., Lambalk, C   +58 more
core   +1 more source

Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer [PDF]

, 2013
Aim: Improving survival for women with early breast cancer (eBC) requires greater attention to the consequences of treatment, including risk to ovarian function. We have assessed whether biochemical markers of the ovarian reserve might improve prediction
Anderson, Richard A., Kelsey, Tom, Rosendahl, Mikkel, Kelsey, Thomas W., Anderson, Richard, Cameron, David A., Cameron, David   +6 more
core   +1 more source